Bottom line
Is APSLX a good fund? The bottom line
APSLX is the Class C share class of NYLI Fiera SMID Growth Fund, a managed small-cap mutual fund from New York Life Investments.
Its expense ratio is 2.05% — about $205 a year on every $10,000 invested, more expensive than 97% of small-cap funds we track.
It returned +3.5% over one year (as of Dec 31, 2025, per its prospectus).
With $201 million in net assets and 79 holdings, its largest position is JFrog Ltd. (3.7%) and the top 10 make up 23.5% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (2.05%)
- 12b-1 marketing fee of 1% a year
Updated Nov 19, 2026
What APSLX invests in
The Fund seeks long term capital growth.
Fiera Capital Inc. (the Subadvisor) seeks to achieve the Funds investment objective by investing in a diversified portfolio of common stocks of companies believed to be small- and mid-cap growth-oriented companies that are selected for their long-term capital appreciation potential and which the Subadvisor expects to grow faster than the U.S. economy. The Fund considers an issuer to be a small- or mid-capitalization issuer if it has a market capitalization, at the time of purchase, within the range of Russell 2500 TM Growth Index (which as of December 31, 2025 ranged from $12.5 million to $37 billion) or the Russell Midcap Growth Index (which as of December 31, 2025 ranged from $1 billion to $101.6 billion). These ranges are subject to change over time due to changes in market and/or economic conditions. The Fund may also invest in exchange-traded funds (ETFs). The Fund may also invest…
From the fund's prospectus (filed Feb 26, 2026).
APSLX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| APSLX | +3.5% | — | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What APSLX costs
On a $10,000 investment, APSLX's 2.05% expense ratio costs about $205 a year. The prospectus estimates $2,188 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
APSLX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | JFrog Ltd. | 3.71% |
| 2 | BWX Technologies, Inc. | 2.63% |
| 3 | EMCOR Group, Inc. | 2.40% |
| 4 | Neurocrine Biosciences, Inc. | 2.27% |
| 5 | Stifel Financial Corp. | 2.23% |
| 6 | MongoDB, Inc. | 2.12% |
| 7 | Argenx SE | 2.09% |
| 8 | Insmed, Inc. | 2.04% |
| 9 | Expedia Group, Inc. | 2.00% |
| 10 | Lattice Semiconductor Corp. | 1.97% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 23.5% of the fund. See all top 25 holdings and asset mix →